tiprankstipranks
Corcept Therapeutics Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsCorcept Therapeutics Reports Q1 2025 Financial Results
14d ago
Closing Bell Movers: Palantir falls 9%, Ford down 2% on earnings
Premium
The Fly
Closing Bell Movers: Palantir falls 9%, Ford down 2% on earnings
14d ago
Corcept Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Corcept Therapeutics Reports Q1 2025 Financial Results
14d ago
Corcept Therapeutics initiates trial of Phase 2 trial BELLA
PremiumThe FlyCorcept Therapeutics initiates trial of Phase 2 trial BELLA
1M ago
Corcept Therapeutics price target raised to $131 from $128 at Piper Sandler
Premium
The Fly
Corcept Therapeutics price target raised to $131 from $128 at Piper Sandler
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Corcept Therapeutics price target raised to $128 from $78 at Piper Sandler
PremiumThe FlyCorcept Therapeutics price target raised to $128 from $78 at Piper Sandler
2M ago
Corcept Therapeutics price target raised to $150 from $76 at Truist
Premium
The Fly
Corcept Therapeutics price target raised to $150 from $76 at Truist
2M ago
Corcept Therapeutics: Promising Future with Positive Trial Results and Strong Market Position
Premium
Ratings
Corcept Therapeutics: Promising Future with Positive Trial Results and Strong Market Position
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100